119 related articles for article (PubMed ID: 9690552)
21. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
22. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
23. Age-related profile of neuroblastoma: a comparison of tumors detected by mass-screening with those detected clinically.
Tanaka T; Tanabe M; Sugimoto T; Ida N; Sawada T
Acta Paediatr Jpn; 1995 Apr; 37(2):154-9. PubMed ID: 7793247
[TBL] [Abstract][Full Text] [Related]
24. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
[TBL] [Abstract][Full Text] [Related]
25. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
26. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
[TBL] [Abstract][Full Text] [Related]
27. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
28. Prenatally detected tumor mass in the adrenal gland.
Lin JN; Lin GJ; Hung IJ; Hsueh C
J Pediatr Surg; 1999 Nov; 34(11):1620-3. PubMed ID: 10591555
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous regression of localized neuroblastoma detected by mass screening.
Yamamoto K; Hanada R; Kikuchi A; Ichikawa M; Aihara T; Oguma E; Moritani T; Shimanuki Y; Tanimura M; Hayashi Y
J Clin Oncol; 1998 Apr; 16(4):1265-9. PubMed ID: 9552024
[TBL] [Abstract][Full Text] [Related]
30. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
31. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
32. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
[TBL] [Abstract][Full Text] [Related]
33. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
34. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
35. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
Kerbl R; Urban CE; Ladenstein R; Schnellauf C; Sitzwohl C; Lackner H; Gleispach H; Fauler G; Ambros PF; Ambros IM; Rumpler S; Gadner H; Spuller E; Höfler G; Amann G; Kytir J; Mutz I
Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
[TBL] [Abstract][Full Text] [Related]
36. Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan.
Kaneko Y; Kobayashi H; Watanabe N; Tomioka N; Nakagawara A
Pediatr Blood Cancer; 2006 Mar; 46(3):285-91. PubMed ID: 16078225
[TBL] [Abstract][Full Text] [Related]
37. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
[TBL] [Abstract][Full Text] [Related]
38. Cases of neuroblastoma missed by the mass screening programs.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J; Kawai T
Pediatr Res; 1989 Dec; 26(6):603-7. PubMed ID: 2602040
[TBL] [Abstract][Full Text] [Related]
39. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
40. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.
De Bernardi B; Pianca C; Boni L; Brisigotti M; Carli M; Bagnulo S; Corciulo P; Mancini A; De Laurentis C; Di Tullio MT
Cancer; 1992 Sep; 70(6):1625-33. PubMed ID: 1516016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
